Tumour Agnostic Treatments and Companion Diagnostics

The rise of precision medicine in Canada has generated a desire to have reliable and accurate methods of identifying patients who will benefit from oncology drug therapies in clinical practice. Precision medicine is directed at delivering the right drug to the right patient at the right time, promising more efficient use of healthcare resources by targeting those patients most likely to respond to the therapy. Precision medicines can identify biological information (genes, RNA/DNA, or proteins) to target those patients most likely to respond to a specific treatment. In precision medicine, diagnosis and treatment are intrinsically linked.